DNA immunization

Trends in Microbiology

Volumn 4, Issue 8, 1996, Pages 307-312

  Hassett, Daniel E ^a   Whitton, J Lindsay ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIVE VACCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PLASMID DNA; RECOMBINANT VACCINE; VACCINE;

CELLULAR IMMUNITY; COST EFFECTIVENESS ANALYSIS; DRUG DESIGN; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; EXPRESSION VECTOR; GENE TARGETING; HUMAN; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; INOCULATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW;

EID: 0030219017     PISSN: 0966842X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0966-842X(96)10048-2     Document Type: Review

References (43)

1. 1 Whitton, J.L. and Oldstone, M.B.A. (1996) in Fields' Virology (3rd Edn) (Fields, B.N., Knipe, D.M. and Howley, P.M., eds), pp. 345-374, Raven Press
2. 2 Good, R.A. (1991) Immunol. Today 12, 283-286
3. 3 Gray, M.M. et al. (1987) Br. Med. J. [Clin. Res.] 295, 19-22
4. 4 Henderson, D.A. (1987) Bull. WHO 65, 535-546
5. 5 Whitton, J.L. et al. (1993) J. Virol. 67, 348-352
6. 6 Foecking, M.K. and Hofstetter, H. (1986) Gene 45, 101-105
7. 7 Chapman, B.S. et al. (1991) Nucleic Acids Res. 19, 3979-3986
8. 8 Felgner, P.L. et al. (1995) Ann. New York Acad. Sci. 772, 126-139
9. 9 Furth, P.A. et al. (1991) Nucleic Acids Res. 19, 6205-6208
10. 10 Thierry, A.R. et al. (1995) Proc. Natl Acad. Sci. USA 92, 9742-9746
11. 11 Xiang, Z.Q. et al. (1995) Virology 209, 569-579
12. 12 Barry, M.A., Lai, W.C. and Johnston, S.A. (1995) Nature 377, 632-635
13. 13 Ulmer, J.B. et al. (1993) Science 259, 1745-1749
14. 14 Nabel, G.J. et al. (1993) Proc. Natl Acad. Sci. USA 90, 11307-11311
15. 15 Vahlsing, H.L. et al. (1994) J. Immunol. Methods 175, 11-22
16. 16 Tang, D.C., DeVit, M. and Johnston, S.A. (1992) Nature 356, 152-154
17. 17 Wolff, J.A. et al. (1992) Hum. Mol. Genet. 1, 363-369
18. 18 Davis, H.L., Michel, M.L. and Whalen, R.G. (1995) Ann. New York Acad. Sci. 772, 21-29
19. 19 Zhu, N. et al. (1993) Science 261, 209-211
20. 20 Whitton, J.L. and Yokoyama, M. in Microbial Pathogenesis and Immune Response II (Ades, E.W., Morse, S.A. and Rest, R.F., eds), New York Academy of Sciences (in press)
21. 21 Yokoyama, M., Zhang, J. and Whitton, J.L. FEMS Immunol. Med. Microbiol. (in press)
22. 22 Salmon, J.K., Armstrong, C.A. and Ansel, J.C. (1994) West. J. Med. 160, 146-152
23. 23 Raz, E. et al. (1994) Proc. Natl Acad. Sci. USA 91, 9519-9523
24. 24 Fynan, E.F. et al. (1993) Proc. Natl Acad. Sci. USA 90, 11478-11482
25. 25 Fynan, E.F. et al. (1995) Int. J. Immunopharm. 17, 79-83
26. 26 Whalen, R.G. and Davis, H.L. (1995) Clin. Immunol. Immunopathol. 75, 1-12
27. 27 Liu, M.A., Hilleman, M.R. and Kurth, R., eds (1995) DNA Vaccines: A New Era in Vaccinology, New York Academy of Sciences
28. 28 Zarozinski, C.C. et al. (1995) J. Immunol. 154, 4010-4017
29. 29 Yokoyama, M., Zhang, J. and Whitton, J.L. (1995) J. Virol. 69, 2684-2688
30. 30 Xiang, Z.Q. et al. (1994) Virology 199, 132-140
31. 31 Sedegah, M. et al. (1994) Proc. Natl Acad. Sci. USA 91, 9866-9870
32. 32 Montgomery, D.L. et al. (1993) DNA Cell Biol. 12, 777-783
33. 33 Yankauckas, M.A. et al. (1993) DNA Cell Biol. 12, 771-776
34. 34 Schirmbeck, R. et al. (1995) J. Virol. 69, 5929-5934
35. 35 Xiang, Z. and Ertl, H.C. (1995) Immunity 2, 129-135
36. 36 Davis, H.L, Michel, M.L. and Whalen, R.G. (1993) Hum. Mol. Genet. 2, 1847-1851
37. 37 Coney, L. et al. (1994) Vaccine 12, 1545-1550
38. 38 Davis, H.L. et al. (1993) Hum. Gene Ther. 4, 733-740
39. 39 Cox, G.J.M., Zamb, T.J. and Babiuk, L.A. (1993) J. Virol. 67, 5664-5667
40. 40 Gilkeson, G.S. et al. (1989) J. ImmunoL 142, 1482-1486
41. 41 Krieg, A.M. et al. (1995) Nature 374, 546-549
42. 42 Temin, H.M. (1990) J. Med. Virol. 31, 13-17
43. 43 Nichols, W.W. et al. (1995) Ann. New York Acad. Sci. 772, 30-39